Skip to main content
. Author manuscript; available in PMC: 2020 Jul 16.
Published in final edited form as: Drug Alcohol Depend. 2018 Nov 6;194:173–177. doi: 10.1016/j.drugalcdep.2018.09.030

Table 2.

MLM predicting Depressive Symptoms as a function of change in smoking and alcohol use.

Parameter B 95% C.I. S.E. p
Mean Level (intercept)
 Intercept 0.36 (−3.67 – 4.40) 2.04 .861
 Baseline CES-D 0.43 (0.28 – 0.58) .07 <.001
 Past MDD (vs. none) 2.72 (0.90 – 4.55) .925 .004
 Male (vs. Female) 0.73 (−1.81 – 3.27) 1.28 .573
 Baseline Cigarettes Per Week 0.07 (−.06 – 0.21) .068 .267
 Baseline Drinks Per Week −0.03 (−0.09 – 0.03) .029 .335
 Naltrexone (vs. Placebo) 0.25 (−2.17 – 2.67) 1.22 .837
Time-varying Smoking Status
 50% or greater reduction (vs. 4.02 (1.70 – 6.33) 1.17 .001
 < 50% reduction (vs. Abstinence) 6.10 (3.22 – 8.98) 1.45 <.001
Time-varying Alcohol Use
 50% or greater reduction vs. .41 (−1.81 – 2.63) 1.13 .717
 < 50% reduction or no change vs. .25 (−1.86 – 2.40) 1.07 .818
Variance Components
Level 1
 Within-person residuals 32.53 (25.87 – 40.90) 3.79 <.001
Level 2
 In mean level (intercept) 22.57 (11.75 – 43.34) 7.51 .003
 In rate of change (time) 2.90 (1.22 – 7.06) 1.31 .026
 In time-varying smoking abstinence 8.53 (2.11 – 34.41) 6.006 .160
 In time-varying alcohol abstinence 0.33 (0.00 – 2.25) 4.55 .937

Note. CES-D = Center for Epidemiologic Studies Depression Scale; MDD = major depressive disorder